Katherine Stueland - 16 Jun 2026 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Jun 2026, 16:09:02 UTC
Prior SEC filing
11 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Bridget Brown, Attorney-in-Fact

Key filing fact

Katherine Stueland filed Form 4 for GeneDx Holdings Corp. (WGS) on 18 Jun 2026.

Key facts

  • This page summarizes Katherine Stueland's Form 4 filing for GeneDx Holdings Corp. (WGS).
  • 5 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 18 Jun 2026, 16:09.

Change

  • Previous filing in this sequence was filed on 11 Jun 2026.
  • Current net transaction value: -$638,104.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001689575 Primary reporting owner

Stueland Katherine

Relationship
CHIEF EXECUTIVE OFFICER, Director
Address
C/O GENEDX HOLDINGS CORP., 333 LUDLOW ST., NORTH TOWER, 6TH FLOOR, STAMFORD
Signature
/s/ Bridget Brown, Attorney-in-Fact
Signature date
18 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WGS transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+18,750
Change %
+20%
Price
$0.000000*
Shares after
114,873
Date
16 Jun 2026
Ownership
Direct
Footnotes
F1
WGS transaction

Class A Common Stock

Sale

Transaction value
$127,874
Shares
-2,140
Change %
-1.9%
Price
$59.75
Shares after
112,733
Date
16 Jun 2026
Ownership
Direct
Footnotes
F2, F3
WGS transaction

Class A Common Stock

Sale

Transaction value
$360,838
Shares
-5,932
Change %
-5.3%
Price
$60.83
Shares after
106,801
Date
16 Jun 2026
Ownership
Direct
Footnotes
F2, F4
WGS transaction

Class A Common Stock

Sale

Transaction value
$149,392
Shares
-2,429
Change %
-2.3%
Price
$61.50
Shares after
104,372
Date
16 Jun 2026
Ownership
Direct
Footnotes
F2, F5, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WGS transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares
-18,750
Change %
-25%
Price
$0.000000*
Shares after
56,250
Date
16 Jun 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
18,750
Exercise price
Footnotes
F1, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.

Footnote F2

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.26 to $60.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.40 to $61.35 per share, inclusive.

Footnote F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.44 to $61.69 per share, inclusive.

Footnote F6

Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 104,372 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 305,525 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms.

Footnote F7

6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .